GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aelis Farma SA (XPAR:AELIS) » Definitions » Price-to-Owner-Earnings

Aelis Farma (XPAR:AELIS) Price-to-Owner-Earnings : (As of Jun. 08, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Aelis Farma Price-to-Owner-Earnings?

As of today (2024-06-08), Aelis Farma's share price is €13.20. Aelis Farma does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Aelis Farma's Price-to-Owner-Earnings or its related term are showing as below:

During the past 7 years, the highest Price-to-Owner-Earnings of Aelis Farma was 7.34. The lowest was 4.62. And the median was 5.93.


XPAR:AELIS's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 33.7
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-08), Aelis Farma's share price is €13.20. Aelis Farma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.39. Therefore, Aelis Farma's PE Ratio for today is At Loss.

As of today (2024-06-08), Aelis Farma's share price is €13.20. Aelis Farma's EPS without NRI for the trailing twelve months (TTM) ended in was €-0.39. Therefore, Aelis Farma's PE Ratio without NRI for today is At Loss.

During the past 7 years, Aelis Farma's highest PE Ratio without NRI was 83.61. The lowest was 0.00. And the median was 67.53.


Aelis Farma Price-to-Owner-Earnings Historical Data

The historical data trend for Aelis Farma's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aelis Farma Price-to-Owner-Earnings Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

Aelis Farma Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Aelis Farma's Price-to-Owner-Earnings

For the Biotechnology subindustry, Aelis Farma's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aelis Farma's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aelis Farma's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Aelis Farma's Price-to-Owner-Earnings falls into.



Aelis Farma Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Aelis Farma's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=13.20/-0.97
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aelis Farma  (XPAR:AELIS) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Aelis Farma Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Aelis Farma's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Aelis Farma (XPAR:AELIS) Business Description

Traded in Other Exchanges
Address
146, rue Leo Saignat, Bordeaux, FRA, 33077
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases.

Aelis Farma (XPAR:AELIS) Headlines

No Headlines